Mozambique

Last Updated 20 October 2021.

1 Vaccine Approved for Use in Mozambique

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 67 countries

  14 trials in 2 countries

  Approval Source: herald.co.zw

  Inactivated

1 Vaccine in Clinical Trials in Mozambique

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 124 countries

  45 trials in 23 countries

  Non Replicating Viral Vector